ATYR Q1 2023 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$755,000

Operating Income

-$13M

Net Income

-$12M

EPS (Diluted)

$-0.29

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$590,000

Free Cash Flow

-$2M

Stock-Based Comp.

$619,000

Balance Sheet

Total Assets

$137M

Total Liabilities

$27M

Stockholders' Equity

$110M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$755,000	$0	—
Operating Income	-$13M	-$12M	-3.3%
Net Income	-$12M	-$12M	+1.7%